about
Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry).Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry.In vivo expression of a conditional TGF-beta1 transgene: no evidence for TGF-beta1 transgene expression in SM22alpha-tTA transgenic miceIntravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque.TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice.Outcomes of 1,090 consecutive, elective, nonselected percutaneous coronary interventions at a community hospital without onsite cardiac surgery.Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries.A critical developmental role for tgfbr2 in myogenic cell lineages is revealed in mice expressing SM22-Cre, not SMMHC-Cre.Correspondence to article: Closure of the femoral artery after cardiac catheterization-A comparison of Angio-Seal, StarClose, and manual compressionMechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cellsLimitations to the use of virtual histology-intravascular ultrasound to detect vulnerable plaque
P50
Q33299794-E5FFD97D-0E1B-45FE-93D6-BB0954FDE9EFQ33486258-279571F2-5767-4466-9CC1-8222D75CF9C4Q33520617-07D09611-D2CE-48F6-9089-0065D3BD19CEQ34557394-4D335360-D198-4883-8C9B-A464EB19B3DDQ36812760-FDBB4F62-1FB2-4EA2-95E1-D121B0B3C51CQ37339703-5021599A-AEA4-4747-A4D5-0F29A28475F2Q42005863-7486A873-DB4B-47CB-BBEE-33A7DB2A229FQ46770128-FD061C97-B84C-4412-AA07-294620B24E14Q52010843-780107FA-7353-4BEA-B5DD-90A522C1A20DQ58830538-FEFF0B56-0AA8-4B2D-A07D-77B80210F666Q80151413-089DC538-7D5B-44B0-920C-D63C84905E6CQ80293008-2CB0BE82-A132-43FE-9562-17F53D500267
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrew D Frutkin
@ast
Andrew D Frutkin
@en
Andrew D Frutkin
@es
Andrew D Frutkin
@nl
Andrew D Frutkin
@sl
type
label
Andrew D Frutkin
@ast
Andrew D Frutkin
@en
Andrew D Frutkin
@es
Andrew D Frutkin
@nl
Andrew D Frutkin
@sl
prefLabel
Andrew D Frutkin
@ast
Andrew D Frutkin
@en
Andrew D Frutkin
@es
Andrew D Frutkin
@nl
Andrew D Frutkin
@sl
P106
P21
P31
P496
0000-0001-8128-7549